W. Umstead John

Insider Reports History

Location
Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by W. Umstead John:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Financial Officer Common Stock 0 $0 $2.51 18 Sep 2024 Direct
G1 Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 0 18 Sep 2024 Direct

Insider Reports Filed by W. Umstead John

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GTHX G1 Therapeutics, Inc. 18 Sep 2024 5 $0 4 Chief Financial Officer 18 Sep 2024, 16:15
GTHX G1 Therapeutics, Inc. 05 Jul 2024 1 -$1.32K 4 Chief Financial Officer 08 Jul 2024, 17:54
GTHX G1 Therapeutics, Inc. 01 Jul 2024 1 $0 4 Chief Financial Officer 03 Jul 2024, 17:24
GTHX G1 Therapeutics, Inc. 13 May 2024 1 -$39K 4 Chief Financial Officer 15 May 2024, 16:11
GTHX G1 Therapeutics, Inc. 20 Mar 2024 1 $0 4 Chief Financial Officer 22 Mar 2024, 16:08
GTHX G1 Therapeutics, Inc. 18 Mar 2024 1 -$19.8K 4 Chief Financial Officer 20 Mar 2024, 16:32
GTHX G1 Therapeutics, Inc. 03 Jan 2024 5 -$2.3K 4 Chief Financial Officer 08 Jan 2024, 06:04
GTHX G1 Therapeutics, Inc. 10 May 2023 1 $0 4 Chief Financial Officer 12 May 2023, 16:19
GTHX G1 Therapeutics, Inc. 15 Mar 2023 2 $0 4 Chief Financial Officer 17 Mar 2023, 16:20
GTHX G1 Therapeutics, Inc. 15 Mar 2023 0 $0 3 Chief Financial Officer 17 Mar 2023, 16:10